Streetbeat News

ETST

Earth Science Tech Inc

Employees

3

Industry

Medicinal and Botanical Manufacturing

Open

0.12

Mkt cap

49M

Volume

230K

High

0.17

P/E Ratio

16.00

52-wk high

0.33

Low

0.12

Div yield

N/A

52-wk low

0.00

Insiders at four companies have recently made notable purchases of their own stock, indicating potential confidence in their respective companies' prospects. Earth Science Tech Director Yovan A. Sanchez bought 50,000 shares, 22nd Century Group Director Andrew Arno acquired 100,000 shares, ADM Endeavors CEO Marc Johnson purchased 453,206 shares, and OPKO Health's 10% owner and Vice Chairman/CTO made significant purchases totaling 1,650,010 shares. These transactions can be a factor for investors considering penny stocks.

Portfolio Pulse from Avi Kapoor

January 09, 2024 | 2:03 pm

Insiders at four companies have recently made notable purchases of their own company's stock, signaling potential confidence in their respective companies' futures. SAB Biotherapeutics' Executive Chairman acquired 11,000 shares, following the announcement of dosing trial participants in Australia. Earth Science Tech's CEO bought 230,000 shares after the company reported a net profit for its fiscal second quarter. Butler National's 10% owner purchased 25,272 shares, subsequent to FAA approval for Avcon Industries' modifications in King Air Model B300 Airplanes. VerifyMe's Director acquired 1,800 shares after the company posted upbeat quarterly results. These transactions may influence investors' perspectives on these penny stocks.

Portfolio Pulse from Lisa Levin

December 01, 2023 | 3:23 pm

Insiders at three companies have recently made notable purchases of their own company's stock. Earth Science Tech CEO Giorgio R Saumat bought 102,416 shares at $0.07 each, after the company reported a net profit for its fiscal second quarter. Vivos CEO and President Michael Korenko purchased 100,000 shares at $0.05 each, despite the stock falling 15% over the past six months. Gossamer Bio COO/CFO Bryan Giraudo acquired 200,000 shares at $0.56 each, following a price target increase from $5 to $6 by Wedbush.

Portfolio Pulse from Lisa Levin

November 15, 2023 | 2:31 pm

The article lists the cannabis stocks that gained and lost on August 25, 2023. Notable gainers include Clever Leaves Holdings (NASDAQ:CLVR) and Skye Bioscience (OTC:SKYE), while notable losers include Australis Capital (OTC:AUSAF) and Red White & Bloom Brands (OTC:RWBYF).

Portfolio Pulse from Benzinga Insights

August 25, 2023 | 9:30 pm

Insiders at Earth Science Tech, Inc. (OTC:ETST), Cosmos Health Inc. (NASDAQ:COSM), and RENN Fund, Inc. (NYSE:RCG) have recently made notable purchases of their companies' shares. This could indicate their confidence in the companies' prospects. Earth Science Tech recently appointed a new CFO, Cosmos Health priced a $5.25 million registered direct offering and concurrent private placement, and RENN Fund has a 52-week high of $2.39.

Portfolio Pulse from Lisa Levin

July 25, 2023 | 12:41 pm

Insiders at four companies have recently made notable purchases of their own stocks. Scott's Liquid Gold-Inc. (OTC:SLGD) Director Daniel Roller acquired 794,067 shares, Augusta Gold Corp. (OTC:AUGG) Executive Chairman Richard Warke bought 5,000 shares, Galectin Therapeutics Inc. (NASDAQ:GALT) Director Kary Eldred purchased 1,598 shares, and Earth Science Tech, Inc. (OTC:ETST) CEO Giorgio R Saumat acquired 50,002 shares.

Portfolio Pulse from Lisa Levin

July 21, 2023 | 11:24 am

Insiders at four penny stocks, HOOKIPA Pharma Inc. (HOOK), 1847 Holdings LLC (EFSH), Organicell Regenerative Medicine, Inc. (OCEL), and Earth Science Tech, Inc. (ETST), have recently made notable purchases. HOOKIPA's CEO bought 10,000 shares, 1847 Holdings' 10% owner acquired 443,413 shares, Organicell's 10% owner purchased 320,710 shares, and Earth Science Tech's CEO bought 3,000 shares. These transactions may indicate the insiders' confidence in their companies' prospects.

Portfolio Pulse from Lisa Levin

July 12, 2023 | 11:32 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.